Evidence map›Paper›PMID 36358597›Full record

ArticleCancers2022

Spermidine/Spermine N1-Acetyltransferase 1 (

Vinith Yathindranath, Nura Safa, Babu V Sajesh, Kelly Schwinghamer, Magimairajan Issai Vanan, Rashid Bux, Daniel S Sitar, Marshall Pitz, Teruna J Siahaan, Donald W Miller

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vinith YathindranathDepartment of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB R3E 0Z3, Canada.
Nura SafaDepartment of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB R3E 0Z3, Canada.
Babu V SajeshCancer Care Manitoba Research Institute-CCMRI, Winnipeg, MB R3E 0V9, Canada.
Kelly SchwinghamerDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047, USA.
Magimairajan Issai VananCancer Care Manitoba Research Institute-CCMRI, Winnipeg, MB R3E 0V9, Canada.ORCID 0000-0003-2015-0615
Rashid BuxBioMark Diagnostics Inc., Richmond, BC V6X 2W2, Canada.
Daniel S SitarDepartment of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB R3E 0Z3, Canada.
Marshall PitzCancer Care Manitoba Research Institute-CCMRI, Winnipeg, MB R3E 0V9, Canada.
Teruna J SiahaanDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047, USA.ORCID 0000-0001-7250-0627
Donald W MillerDepartment of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB R3E 0Z3, Canada.ORCID 0000-0003-1952-5635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spermidine/spermine N1-acetyltransferase 1 (

Indexed as

blood–brain barrier (BBB)brain drug deliverycadherin peptidegene therapyglioblastoma (GB)lipid nanoparticlesmicrofluidic mixingsiRNASpermidine/spermine N1-acetyltransferase 1 (SAT1)transient modulationtumor sensitization

Identifiers

PMID36358597
PMCPMC9656607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.